Business Context and Reporting Period
This Form 8-K Current Report was filed by CareDx, Inc. on September 7, 2022. The filing primarily addresses executive leadership changes and associated compensatory arrangements effective as of the report date.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It is a current report focused on corporate governance and personnel rather than financial performance.
Material Changes
The report details the following executive appointments and role transitions effective September 7, 2022:
- Abhishek Jain was appointed Chief Financial Officer (CFO), transitioning from Interim CFO. His annualized salary increased from $305,000 to $375,000, and his target annual performance bonus increased from 35% to 60% of base salary. He received an option to purchase 60,000 shares and 22,150 restricted stock units (RSUs).
- Abraham Ronai was appointed Chief Administrative & Legal Officer and Secretary. His target annual performance bonus increased from 50% to 60% of base salary, while his annualized salary remained at $388,125. He received an option to purchase 36,000 shares and 12,000 RSUs.
- Alexander L. Johnson transitioned from Chief Business Officer and Head of Testing Services to President of Patient and Testing Services.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. No specific risks or contingencies are disclosed in this document other than the standard vesting conditions tied to continued employment for the new equity grants.
Investor Verification Checklist
- Verify the vesting schedules for the new equity grants (options and RSUs) issued to Mr. Jain and Mr. Ronai.
- Confirm the impact of the increased compensation packages on the company's future operating expenses.
- Review the company's most recent 10-Q or 10-K for actual financial performance metrics, as this 8-K does not contain them.